vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $17.2M, roughly 1.7× Invivyd, Inc.). Invivyd, Inc. runs the higher net margin — -64.3% vs -438.1%, a 373.8% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 24.5%).
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
DOMH vs IVVD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $17.2M |
| Net Profit | $-131.8M | $-11.1M |
| Gross Margin | — | — |
| Operating Margin | -8.9% | -73.0% |
| Net Margin | -438.1% | -64.3% |
| Revenue YoY | 220.4% | 24.5% |
| Net Profit YoY | -12426.2% | 40.0% |
| EPS (diluted) | $-6.94 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $17.2M | ||
| Q3 25 | $50.8M | $13.1M | ||
| Q2 25 | $34.1M | $11.8M | ||
| Q1 25 | $8.1M | $11.3M | ||
| Q4 24 | $9.4M | $13.8M | ||
| Q3 24 | $4.0M | $9.3M | ||
| Q2 24 | $6.2M | $2.3M | ||
| Q1 24 | $1.4M | $0 |
| Q4 25 | $-131.8M | $-11.1M | ||
| Q3 25 | $125.2M | $-10.5M | ||
| Q2 25 | $16.6M | $-14.7M | ||
| Q1 25 | $-32.5M | $-16.3M | ||
| Q4 24 | $1.1M | $-18.4M | ||
| Q3 24 | $-4.2M | $-60.7M | ||
| Q2 24 | $-6.1M | $-47.2M | ||
| Q1 24 | $-5.4M | $-43.5M |
| Q4 25 | -8.9% | -73.0% | ||
| Q3 25 | -3.1% | -84.0% | ||
| Q2 25 | -57.0% | -127.8% | ||
| Q1 25 | -394.6% | -149.7% | ||
| Q4 24 | 0.4% | -139.1% | ||
| Q3 24 | -79.1% | -670.0% | ||
| Q2 24 | -44.3% | -2175.2% | ||
| Q1 24 | -205.2% | — |
| Q4 25 | -438.1% | -64.3% | ||
| Q3 25 | 246.4% | -79.7% | ||
| Q2 25 | 48.7% | -124.4% | ||
| Q1 25 | -400.5% | -144.1% | ||
| Q4 24 | 11.4% | -133.5% | ||
| Q3 24 | -104.2% | -653.1% | ||
| Q2 24 | -99.1% | -2086.9% | ||
| Q1 24 | -398.0% | — |
| Q4 25 | $-6.94 | $0.02 | ||
| Q3 25 | $7.27 | $-0.06 | ||
| Q2 25 | $1.12 | $-0.12 | ||
| Q1 25 | $-3.02 | $-0.14 | ||
| Q4 24 | $0.21 | $-0.14 | ||
| Q3 24 | $-0.67 | $-0.51 | ||
| Q2 24 | $-1.01 | $-0.40 | ||
| Q1 24 | $-0.91 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $226.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $241.5M |
| Total Assets | $112.9M | $276.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $226.7M | ||
| Q3 25 | $176.2M | $85.0M | ||
| Q2 25 | $28.2M | $34.9M | ||
| Q1 25 | $18.9M | $48.1M | ||
| Q4 24 | $8.2M | $69.3M | ||
| Q3 24 | $7.2M | $106.9M | ||
| Q2 24 | $12.1M | $147.9M | ||
| Q1 24 | $7.1M | $189.4M |
| Q4 25 | $69.4M | $241.5M | ||
| Q3 25 | $210.2M | $93.1M | ||
| Q2 25 | $88.6M | $42.8M | ||
| Q1 25 | $42.4M | $54.1M | ||
| Q4 24 | $39.9M | $67.5M | ||
| Q3 24 | $38.3M | $83.2M | ||
| Q2 24 | $42.4M | $140.6M | ||
| Q1 24 | $47.7M | $178.5M |
| Q4 25 | $112.9M | $276.9M | ||
| Q3 25 | $223.4M | $139.2M | ||
| Q2 25 | $109.3M | $89.1M | ||
| Q1 25 | $52.3M | $103.7M | ||
| Q4 24 | $47.1M | $129.5M | ||
| Q3 24 | $43.4M | $161.9M | ||
| Q2 24 | $49.1M | $177.3M | ||
| Q1 24 | $52.2M | $215.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $-15.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $-15.5M | ||
| Q3 25 | $-4.9M | $-8.3M | ||
| Q2 25 | $-353.0K | $-13.3M | ||
| Q1 25 | $1.2M | $-21.1M | ||
| Q4 24 | $-16.7M | $-37.6M | ||
| Q3 24 | $-4.7M | $-41.1M | ||
| Q2 24 | $1.4M | $-41.6M | ||
| Q1 24 | $-8.6M | $-50.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-13.3M | ||
| Q1 25 | — | $-21.3M | ||
| Q4 24 | — | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-50.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -112.9% | ||
| Q1 25 | — | -188.2% | ||
| Q4 24 | — | -272.2% | ||
| Q3 24 | — | -441.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
IVVD
Segment breakdown not available.
